Upcoming ACT EU Multi-stakeholder Workshop on ICH E6 R3
As part of the published Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan 2022-2026 and acknowledging the important role of International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Efficiency...
IMPORTANT MESSAGE FROM ACT EU
All clinical trials expected to continue beyond 30 January 2025 must be transitioned to the EU Clinical Trials Regulation (CTR) via the Clinical Trials Information System (CTIS). This date marks the end of a three-year transition period that began when the CTR became...
Multi-stakeholder Interview: Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Innovation and Access in Rare Cancers
The Cancer Drug Development Forum (CDDF) is delighted to share interview clips featuring a diverse group of stakeholders from our recent Multi-Stakeholder Workshop on Innovation and Access in Rare Cancers. Held in Amsterdam on 23-24 September 2024, the meeting...